within Pharmacolibrary.Drugs.ATC.S;

model S01JA01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 1.8500000000000002e-05,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00041999999999999996,
    k12             = 0.68,
    k21             = 0.68
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01JA01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Fluorescein is a synthetic organic compound used primarily as a diagnostic dye in ophthalmology for the assessment of corneal abrasions, vascular disorders, and to visualize blood vessels in the eye. It is approved for clinical use and is widely used today both topically and intravenously for retinal angiography.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following intravenous bolus administration.</p><h4>References</h4><ol><li><p>Millul, J, et al., &amp; Cazzamalli, S (2021). An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications. <i>Proceedings of the National Academy of Sciences of the United States of America</i> 118(16) –. DOI:<a href=\"https://doi.org/10.1073/pnas.2101852118\">10.1073/pnas.2101852118</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33850024/\">https://pubmed.ncbi.nlm.nih.gov/33850024</a></p></li><li><p>Blair, NP, et al., &amp; Zeimer, RC (1986). Fluorescein and fluorescein glucuronide pharmacokinetics after intravenous injection. <i>Investigative ophthalmology &amp; visual science</i> 27(7) 1107–1114. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3721789/\">https://pubmed.ncbi.nlm.nih.gov/3721789</a></p></li><li><p>Palestine, AG, &amp; Brubaker, RF (1981). Pharmacokinetics of fluorescein in the vitreous. <i>Investigative ophthalmology &amp; visual science</i> 21(4) 542–549. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7287343/\">https://pubmed.ncbi.nlm.nih.gov/7287343</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01JA01;
